Cephalon Makes A Deal
Amrix was developed by the recently IPOed Italian drugmaker Eurand and then out-licensed to privately held ECR Pharmaceuticals, which licensed it to Cephalon. via Fool.com
Join the discussion below, or Read more at Fool.com.
#1 Aug 27, 2007
Very interesting indeed.
Add your comments below
|Earnings Preview: Pfizer to report 2Q earnings (Aug '10)||Jan '16||Sharolyn||18|
|Wyeth's Pristiq, A New Treatment For Major Depr... (May '08)||Jan '14||Vikkie||3|
|Wyeth's Pristiq, a New Treatment for Major Depr... (Jul '08)||Jan '14||Trixy||6|
|Lilly's Results Run the Gamut (Oct '08)||Sep '13||Hugh||2|
|Wyeth to Pay $134.5M in Hormone Drug Case (Nov '07)||Sep '13||Elliot||8|
|Wyeth hit with $134.5M judgment over hormone re... (Oct '07)||Sep '13||William||3|
|ativan untill 2003 Wyeth product (Feb '08)||Mar '13||patient||9|
Find what you want!
Search Wyeth Forum Now
Copyright © 2017 Topix LLC